Medtronic received information via literature regarding the postoperative outcomes of stentless bioprosthetic valves in patients undergoing aortic root replacement following valvular endocarditis.All data were collected from a single center between february 2000 and june 2010.The study population included 180 patients (predominantly female, mean age 66.7 years, mean weight 73.2 kg), 18 of which were implanted with medtronic freestyle bioprosthetic aortic root replacements (no serial numbers provided).Among all medtronic freestyle patients, 2 deaths occurred in-hospital because of septic shock.Based on the available information medtronic product was not directly associated with the deaths.Among all medtronic freestyle patients, adverse events included: major bleeding, pseudoaneurysm, and low cardiac output.One patient required reintervention for major bleeding.Two patients required reintervention because of a pseudoaneurysm at 1 month and 23 months post implant of the freestyle valve.The authors attributed the pseudoaneurysms to native tissue degeneration and excessive use of gelatine resorcinol formaldehyde glue, respectively.Based on the available information medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
|